Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors.

Regulation of lineage-restricted transcription factors has been shown to influence malignant transformation in several types of cancer. Whether similar mechanisms are involved in ovarian cancer pathogenesis is unknown. PAX8 is a nuclear transcription factor that controls the embryologic development of the Müllerian system, including the fallopian tubes. Recent studies have shown that fallopian tube secretory epithelial cells (FTSECs) give rise to the most common form of ovarian cancer, high-grade serous ovarian carcinomas (HGSOCs). We designed the present study in order to understand whether changes in gene expression between FTSECs and HGSOCs relate to alterations in PAX8 binding to chromatin. Using whole transcriptome shotgun sequencing (RNA-Seq) after PAX8 knockdown and ChIP-Seq, we show that FTSECs and HGSOCs are distinguished by marked reprogramming of the PAX8 cistrome. Genes that are significantly altered between FTSECs and HGSOCs are enriched near PAX8 binding sites. These sites are also near TEAD binding sites, and these transcriptional changes may be related to PAX8 interactions with the TEAD/YAP1 signaling pathway. These data suggest that transcriptional changes after transformation in ovarian cancer are closely related to epigenetic remodeling in lineage-specific transcription factors.

[1]  S. Aerts,et al.  Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells , 2015, eLife.

[2]  R. Drapkin,et al.  Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival. , 2010, Neoplasia.

[3]  J. Marto,et al.  Primary ex-vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis , 2009, Oncogene.

[4]  Antonio Rosato,et al.  Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth , 2015, Nature Cell Biology.

[5]  Jennifer A. Mitchell,et al.  Chromatin Dynamics in Lineage Commitment and Cellular Reprogramming , 2015, Genes.

[6]  Marcin Imielinski,et al.  Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers , 2015, Nature Genetics.

[7]  Clifford A. Meyer,et al.  Cistrome: an integrative platform for transcriptional regulation studies , 2011, Genome Biology.

[8]  G. Enikolopov,et al.  Ovarian surface epithelium at the junction area contains cancer-prone stem cell niche , 2013, Nature.

[9]  I. Clay,et al.  YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers , 2015, PLoS genetics.

[10]  V. Velculescu,et al.  Beyond genomics: critical evaluation of cell line utility for ovarian cancer research. , 2015, Gynecologic oncology.

[11]  M. Loda,et al.  A Comprehensive Analysis of PAX8 Expression in Human Epithelial Tumors , 2011, The American journal of surgical pathology.

[12]  G. Schaffner,et al.  DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site. , 1993, Genes & development.

[13]  R. Drapkin,et al.  It's Totally Tubular....Riding The New Wave of Ovarian Cancer Research. , 2016, Cancer research.

[14]  M. Noll,et al.  Conservation of a large protein domain in the segmentation gene paired and in functionally related genes of Drosophila , 1986, Cell.

[15]  R. Drapkin,et al.  Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms , 2013, Front. Oncol..

[16]  Gregory A. Wyant,et al.  Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. , 2013, Cancer cell.

[17]  J. Mesirov,et al.  Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer , 2011, Proceedings of the National Academy of Sciences.

[18]  Jill P. Mesirov,et al.  Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4 , 2012, Science Translational Medicine.

[19]  R. Drapkin,et al.  Modeling high-grade serous ovarian carcinogenesis from the fallopian tube , 2011, Proceedings of the National Academy of Sciences.

[20]  R. Drapkin,et al.  YAP Induces High-Grade Serous Carcinoma in Fallopian Tube Secretory Epithelial Cells , 2015, Oncogene.

[21]  David R. Kelley,et al.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.

[22]  Xiaohua Wu,et al.  High Expressions of Lgr5 and ALDH1 in Primary Epithelial Ovarian Cancer Correlate with Advanced Tumor Stage and Grade as well as Poor Prognosis of the Patients , 2015, Gynecologic and Obstetric Investigation.

[23]  Jun S. Song,et al.  YY1 Regulates Melanocyte Development and Function by Cooperating with MITF , 2012, PLoS genetics.

[24]  K. Guan,et al.  YAP and TAZ: a nexus for Hippo signaling and beyond. , 2015, Trends in cell biology.

[25]  Clifford A. Meyer,et al.  Chromosome-Wide Mapping of Estrogen Receptor Binding Reveals Long-Range Regulation Requiring the Forkhead Protein FoxA1 , 2005, Cell.

[26]  A. Tinker,et al.  The role of the fallopian tube in ovarian cancer. , 2012, Clinical advances in hematology & oncology : H&O.

[27]  D. Pisano,et al.  Genome-wide analysis of Pax8 binding provides new insights into thyroid functions , 2012, BMC Genomics.

[28]  P. Gruss,et al.  Pax genes and their role in organogenesis. , 1999, Cancer research.

[29]  M. Zannini,et al.  A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells , 2014, BMC Cancer.

[30]  E. Winterhager,et al.  Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy. , 2007, Endocrinology.

[31]  E. Zammarchi,et al.  Role for p300 in Pax 8 Induction of Thyroperoxidase Gene Expression* , 2000, The Journal of Biological Chemistry.

[32]  R. Drapkin,et al.  PAX8 Reliably Distinguishes Ovarian Serous Tumors From Malignant Mesothelioma , 2010, The American journal of surgical pathology.

[33]  P Gruss,et al.  Pax genes and their roles in cell differentiation and development. , 1996, Current opinion in cell biology.

[34]  C. Sander,et al.  Evaluating cell lines as tumour models by comparison of genomic profiles , 2013, Nature Communications.

[35]  A. Jolma,et al.  DNA-dependent formation of transcription factor pairs alters their binding specificity , 2015, Nature.

[36]  C. Antonescu,et al.  ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours , 2010, Nature.

[37]  M. Goulding,et al.  The molecular basis of the undulated/Pax-1 mutation , 1991, Cell.

[38]  Karen D. Cowden Dahl,et al.  In vivo tumor growth of high-grade serous ovarian cancer cell lines. , 2015, Gynecologic oncology.

[39]  Sridhar Ramaswamy,et al.  Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability , 2002, Cell.

[40]  Joaquim Bellmunt,et al.  Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles , 2016, Nature Medicine.

[41]  S. Shah,et al.  Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research , 2013, PloS one.

[42]  R. Drapkin,et al.  Primary culture and immortalization of human fallopian tube secretory epithelial cells , 2012, Nature Protocols.

[43]  D. Katsaros,et al.  The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[44]  C. Crum,et al.  Serous Tubal Intraepithelial Carcinoma and the Dominant Ovarian Mass: Clues to Serous Tumor Origin? , 2009, The American journal of surgical pathology.

[45]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[46]  Christopher P Crum,et al.  Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. , 2005, Cancer research.

[47]  M. Dimopoulos,et al.  Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis , 2009, Thrombosis and Haemostasis.

[48]  G. Daley,et al.  A role for Lin28 in primordial germ cell development and germ cell malignancy , 2009, Nature.

[49]  M. Noll,et al.  Structure of the segmentation gene paired and the Drosophila PRD gene set as part of a gene network , 1986, Cell.

[50]  G. Mills,et al.  Elafin drives poor outcome in high grade serous ovarian cancers and basal-like breast tumors , 2013, Oncogene.